Carbonic anhydrase inhibitors: CA IX selective inhibitors incorporating aromatic or heterocyclic sulfonamide

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.15, Iss.2, 2005-02, pp. : 233-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024

By Carradori Simone

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 6, 2013-06 ,pp. : 751-756

Informa Healthcare

Access to resources Recommend Favorite

Carbonic anhydrase inhibitors: an editorial

By Supuran Claudiu T

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 6, 2013-06 ,pp. : 677-679

Informa Healthcare

Access to resources Recommend Favorite

Safety of carbonic anhydrase inhibitors

By Swenson Erik R

Expert Opinion on Drug Safety, Vol. 13, Iss. 4, 2014-04 ,pp. : 459-472

Informa Healthcare

Access to resources Recommend Favorite

Antiobesity Carbonic Anhydrase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 9, 2007-05 ,pp. : 879-884

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic anhydrase IX inhibitors: fluorescent sulfonamides as therapeutic and diagnostic agents

By Winum Jean-Yves

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 11, 2007-11 ,pp. : 1393-1396

Informa Healthcare

Access to resources Recommend Favorite